Detalles de la búsqueda
1.
Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study.
BMC Cancer
; 19(1): 896, 2019 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31500587
2.
Real-world multicenter study of the safety and efficacy of netupitant plus palonosetron fixed-dose combination to prevent chemotherapy-induced nausea and vomiting among Malaysian patients receiving moderately or highly emetogenic chemotherapy.
Asia Pac J Clin Oncol
; 18(4): 419-427, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34811924
Resultados
1 -
2
de 2
1
Próxima >
>>